These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 28045923)
1. Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. Makhoul I; Todorova VK; Siegel ER; Erickson SW; Dhakal I; Raj VR; Lee JY; Orloff MS; Griffin RJ; Henry-Tillman RS; Klimberg S; Hutchins LF; Kadlubar SA PLoS One; 2017; 12(1):e0168550. PubMed ID: 28045923 [TBL] [Abstract][Full Text] [Related]
2. Genetic Variants of Gaibar M; Galán M; Romero-Lorca A; Antón B; Malón D; Moreno A; Fernández-Santander A; Novillo A Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573134 [TBL] [Abstract][Full Text] [Related]
3. High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer. Makhoul I; Griffin RJ; Siegel E; Lee J; Dhakal I; Raj V; Jamshidi-Parsian A; Klimberg S; Hutchins LF; Kadlubar S Am J Clin Oncol; 2016 Jun; 39(3):248-54. PubMed ID: 24577164 [TBL] [Abstract][Full Text] [Related]
4. Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study. Hein A; Lambrechts D; von Minckwitz G; Häberle L; Eidtmann H; Tesch H; Untch M; Hilfrich J; Schem C; Rezai M; Gerber B; Dan Costa S; Blohmer JU; Schwedler K; Kittel K; Fehm T; Kunz G; Beckmann MW; Ekici AB; Hanusch C; Huober J; Liedtke C; Mau C; Moisse M; Müller V; Nekljudova V; Peuteman G; Rack B; Rübner M; Van Brussel T; Wang L; Weinshilboum RM; Loibl S; Fasching PA Int J Cancer; 2015 Dec; 137(12):2981-8. PubMed ID: 26100253 [TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer. Gampenrieder SP; Hufnagl C; Brechelmacher S; Huemer F; Hackl H; Rinnerthaler G; Romeder F; Monzo Fuentes C; Morre P; Hauser-Kronberger C; Mlineritsch B; Greil R Pharmacogenomics J; 2017 Jul; 17(4):344-350. PubMed ID: 27139155 [TBL] [Abstract][Full Text] [Related]
6. Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases. Stremitzer S; Zhang W; Yang D; Ning Y; Stintzing S; Sebio A; Sunakawa Y; Yamauchi S; Matsusaka S; El-Khoueiry R; Stift J; Wrba F; Gruenberger T; Lenz HJ Cancer; 2015 Jun; 121(11):1898-905. PubMed ID: 25690670 [TBL] [Abstract][Full Text] [Related]
7. Divergent regulation of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor by hypoxia and female sex steroids in human endometrial stromal cells. Tsuzuki T; Okada H; Cho H; Shimoi K; Miyashiro H; Yasuda K; Kanzaki H Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):95-101. PubMed ID: 23352606 [TBL] [Abstract][Full Text] [Related]
8. Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab. Ingle JN; Kalari KR; Wickerham DL; von Minckwitz G; Fasching PA; Furukawa Y; Mushiroda T; Goetz MP; Barman P; Carlson EE; Rastogi P; Costantino JP; Cairns J; Paik S; Bear HD; Kubo M; Wang L; Wolmark N; Weinshilboum RM Pharmacogenet Genomics; 2018 Jun; 28(6):147-152. PubMed ID: 29768301 [TBL] [Abstract][Full Text] [Related]
9. No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women. Dorjgochoo T; Zheng Y; Gao YT; Ma X; Long J; Bao P; Zhang B; Wen W; Lu W; Zheng W; Shu XO; Beeghly-Fadiel A Cancer Epidemiol; 2013 Oct; 37(5):619-24. PubMed ID: 23850146 [TBL] [Abstract][Full Text] [Related]
10. Angiopoietin pathway gene expression associated with poor breast cancer survival. Ramanathan R; Olex AL; Dozmorov M; Bear HD; Fernandez LJ; Takabe K Breast Cancer Res Treat; 2017 Feb; 162(1):191-198. PubMed ID: 28062977 [TBL] [Abstract][Full Text] [Related]
11. Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. Schneider BP; Wang M; Radovich M; Sledge GW; Badve S; Thor A; Flockhart DA; Hancock B; Davidson N; Gralow J; Dickler M; Perez EA; Cobleigh M; Shenkier T; Edgerton S; Miller KD; J Clin Oncol; 2008 Oct; 26(28):4672-8. PubMed ID: 18824714 [TBL] [Abstract][Full Text] [Related]
12. MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study. Tabouret E; Bertucci F; Pierga JY; Petit T; Levy C; Ferrero JM; Campone M; Gligorov J; Lerebours F; Roché H; Bachelot T; van Laere S; Ueno NT; Toiron Y; Finetti P; Birnbaum D; Borg JP; Viens P; Chinot O; Gonçalves A Oncotarget; 2016 Apr; 7(14):18531-40. PubMed ID: 26921265 [TBL] [Abstract][Full Text] [Related]
13. Age- and BMI-Associated Expression of Angiogenic Factors in White Adipose Tissue of Children. Gaebler N; Haggenmüller B; Kapapa M; Serra A; Tews D; Funcke JB; Brandt S; Ioannidis V; Schön M; Möller P; Debatin KM; Wabitsch M; Fischer-Posovszky P Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31640116 [TBL] [Abstract][Full Text] [Related]
14. Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins. Breunis WB; Davila S; Shimizu C; Oharaseki T; Takahashi K; van Houdt M; Khor CC; Wright VJ; Levin M; Burns JC; Burgner D; Hibberd ML; Kuijpers TW; Arthritis Rheum; 2012 Jan; 64(1):306-15. PubMed ID: 21905000 [TBL] [Abstract][Full Text] [Related]
15. Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study. Slattery ML; John EM; Torres-Mejia G; Lundgreen A; Lewinger JP; Stern MC; Hines L; Baumgartner KB; Giuliano AR; Wolff RK Int J Cancer; 2014 Feb; 134(3):629-44. PubMed ID: 23832257 [TBL] [Abstract][Full Text] [Related]
16. Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Höglander EK; Nord S; Wedge DC; Lingjærde OC; Silwal-Pandit L; Gythfeldt HV; Vollan HKM; Fleischer T; Krohn M; Schlitchting E; Borgen E; Garred Ø; Holmen MM; Wist E; Naume B; Van Loo P; Børresen-Dale AL; Engebraaten O; Kristensen V Genome Med; 2018 Nov; 10(1):92. PubMed ID: 30497530 [TBL] [Abstract][Full Text] [Related]
17. High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer. Negri F; Bozzetti C; Pedrazzi G; Azzoni C; Bottarelli L; Squadrilli A; Lagrasta C; Tamagnini I; Bisagni A; Ragazzi M; Porzio R; Tomasello G; Mori D; Leonardi F; Gnetti L; Crafa P; Sala R; Cascinu S Oncol Rep; 2019 Dec; 42(6):2750-2758. PubMed ID: 31578584 [TBL] [Abstract][Full Text] [Related]
18. [The regulating roles of angiopoietins/TEK-2 in angiogenesis]. Luo Y; Wei YQ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):63-6. PubMed ID: 16456789 [TBL] [Abstract][Full Text] [Related]
19. Analysis of angiogenic markers in oral squamous cell carcinoma-gene and protein expression. Jung S; Sielker S; Purcz N; Sproll C; Acil Y; Kleinheinz J Head Face Med; 2015 Jun; 11():19. PubMed ID: 26044849 [TBL] [Abstract][Full Text] [Related]
20. Association of angiopoietin-1, angiopoietin-2 and caspase-5 polymorphisms with psoriasis vulgaris. He L; Dang L; Zhou J; Bai J; Li YZ Clin Exp Dermatol; 2015 Jul; 40(5):556-63. PubMed ID: 25753570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]